MicroRNA regulation of epigenetic modifiers in breast cancer

B Humphries, Z Wang, C Yang - Cancers, 2019 - mdpi.com
Epigenetics refers to the heritable changes in gene expression without a change in the DNA
sequence itself. Two of these major changes include aberrant DNA methylation as well as …

DNA methylation status in cancer disease: modulations by plant-derived natural compounds and dietary interventions

K Jasek, P Kubatka, M Samec, A Liskova, K Smejkal… - Biomolecules, 2019 - mdpi.com
The modulation of the activity of DNA methyltransferases (DNMTs) represents a crucial
epigenetic mechanism affecting gene expressions or DNA repair mechanisms in the cells …

Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers

M Panagopoulou, M Karaglani, I Balgkouranidou… - Oncogene, 2019 - nature.com
Blood circulating cell-free DNA (ccfDNA) is a suggested biosource of valuable clinical
information for cancer, meeting the need for a minimally-invasive advancement in the route …

BET proteins regulate homologous recombination‐mediated DNA repair: BRCAness and implications for cancer therapy

C Mio, L Gerratana, M Bolis… - … journal of cancer, 2019 - Wiley Online Library
Bromodomain and Extra‐Terminal (BET) proteins are historically involved in regulating gene
expression and BRD4 was recently found to be involved in DNA damage regulation. Aims of …

Paclitaxel response can be predicted with interpretable multi-variate classifiers exploiting DNA-methylation and miRNA data

A Bomane, A Gonçalves, PJ Ballester - Frontiers in genetics, 2019 - frontiersin.org
To address the problem of resistance to paclitaxel treatment, we have investigated to which
extent is possible to predict Breast Cancer (BC) patient response to this drug. We carried out …

[PDF][PDF] Obesity and menopause modify the epigenomic profile of breast cancer

AB Crujeiras, A Diaz-Lagares, OA Stefansson… - Endocr Relat …, 2017 - researchgate.net
Obesity is a high risk factor for breast cancer. This relationship could be marked by a specific
methylome. The current work was aimed to explore the impact of obesity and menopausal …

Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine …

S Liu, P Yin, SA Kujawa, JS Coon, I Okeigwe, SE Bulun - Oncogene, 2019 - nature.com
Progesterone and its receptor, PR, are essential for uterine leiomyoma (LM, aka, fibroid)
tumorigenesis, but the underlying cellular and molecular mechanisms remain unclear. The …

Trop-2 induces tumor growth through AKT and determines sensitivity to AKT inhibitors

E Guerra, M Trerotola, R Tripaldi, AL Aloisi… - Clinical Cancer …, 2016 - AACR
Purpose: Inhibition of AKT is a key target area for personalized cancer medicine. However,
predictive markers of response to AKT inhibitors are lacking. Correspondingly, the AKT …

Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients

M Spitzwieser, E Entfellner, B Werner, W Pulverer… - BMC cancer, 2017 - Springer
Background Breast carcinogenesis is a multistep process involving genetic and epigenetic
changes. Tumor tissues are frequently characterized by gene-specific hypermethylation and …

[HTML][HTML] Identification of lncRNA biomarkers for lung cancer through integrative cross-platform data analyses

T Zhao, VS Khadka, Y Deng - Aging (Albany NY), 2020 - ncbi.nlm.nih.gov
Identification of lncRNA biomarkers for lung cancer through integrative cross-platform data
analyses - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …